Delivery Order SPE2DB24D8002-SPE2DB24FJMYQ
Award Date
9/17/24
Potential Completion Date
9/18/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,570.36, is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, to support the medical supply chain needs of the U.S. Department of Defense. The contract has a completion date of December 1, 2023, and is a Firm Fixed Price Delivery Order. Dakota Drug, Inc. also holds a larger Indefinite Delivery Contract...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA). The contract, valued at $8,358.56, is a firm fixed-price delivery order for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The award has an ultimate completion date of February 11, 2025. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a range of pharmaceutical and medical products to support U.S. Armed...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,628.80, is for the delivery of Trelegy Ellipta 200-62.5-25 60s inhalers. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2023. The award is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare...
This federal contract award, valued at $1,983.62, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a firm fixed-price delivery order for the provision of the prescription medication Trelegy Ellipta 200-62.5-25 60s. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a...
This federal contract award, with ID SPE2DX15D8001|SPE2DX24FBQXN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,834.67 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a period of performance through May 13, 2024. Dakota Drug, Inc. is a critical vendor for the DLA's medical supply chain, holding a substantial...
This federal contract award, ID SPE2DB24D8001|SPE2DB25FKZMW, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract has a ceiling value of $4,312.20 and a period of performance through April 10, 2025. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $6,262.22 firm-fixed-price delivery order is for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S, with a period of performance ending on May 22, 2025. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows...
This federal contract award, SPE2DB24D8003|SPE2DB25FJTKW, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract has a firm fixed price of $2,734.80 and a completion date of December 10, 2024. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 as part of...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract, identified as SPE2DX15D8003|SPE2DX24F7E4R, has a total ceiling value of $2,088.72 and a completion date of July 1, 2024. It is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division. Dakota Drug, Inc. is a key supplier of pharmaceutical and...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract has a ceiling value of $15,991.71 and a period of performance through January 15, 2025. This delivery order was placed under Dakota Drug's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which is part of the DLA Troop Support...